Arrhythmia Research Technology has the Lowest Beta in the Health Care Technology Industry (HRT, SLP, CPSI, OMCL, MDAS)
Below are the three companies in the Health Care Technology industry with the lowest betas. Lower-beta stocks mean minimal volatility and are therefore generally considered to be a less risk and offer more stable returns.
Arrhythmia Research Technology ranks lowest with a a beta of 0.2. Following is Simulations Plus with a a beta of 0.6. Computer Programs & Systems ranks third lowest with a a beta of 0.9.
Omnicell follows with a a beta of 1.0, and MedAssets rounds out the bottom five with a a beta of 1.0.
SmarTrend recommended that subscribers consider buying shares of MedAssets on October 8th, 2015 as our technology indicated a new Uptrend was in progress when shares hit $21.90. Since that recommendation, shares of MedAssets have risen 43.2%. We continue to monitor MedAssets for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: lowest beta amex:hrt arrhythmia research technology simulations plus computer programs & systems omnicell medassets